🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 63937X202 (prev. 63937X103 )
- Market Cap
- Micro Cap
- Previous Symbol
- NEOP (changed 1/5/2012)
- Previous Name
- Neoprobe Corp.
Business: Navidea Biopharmaceuticals, Inc. is a leader in precision medicine with immuno-targeted products designed to help identify the sites and pathways of undetected disease and enable better diagnostic accuracy, clinical decision-making, targeted treatment and, ultimately, patient care.
Notes: April 19, 2019 -- Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB), today announced that its Board of Directors has approved a one-for-twenty reverse stock split of its issued and outstanding shares of common stock. The reverse split will be effective at 12:01 a.m. (EDT) on April 26, 2019. The Company's common stock will continue to trade on the NYSE American under the trading symbol "NAVB," but will trade under the following new CUSIP number starting April 26, 2019: 63937X202.
Company Contact
- CEO
- Jed A. Latkin
- CFO
- Craig A. Dais
- Headquarters
- 4995 Bradenton Avenue, Suite 240, Dublin, OH 43017
- Phone
- 614-793-7500 · Toll-Free 800-793-0079
- Fax
- 614-793-7520
- Investor Relations
- Jeffrey Smith · 614-822-2365 · jsmith@navidea.com